|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Brock MV, Gou M, Akiyama Y, Muller A, Wu
TT, Montgomery E, Deasel M, Germonpré P, Rubinson L, Heitmiller RF,
et al: Prognostic importance of promoter hypermethylation of
multiple genes in esophageal adenocarcinoma. Clin Cancer Res.
9:2912–2919. 2003.PubMed/NCBI
|
|
4
|
Thrumurthy SG, Chaudry MA, Thrumurthy SSD
and Mughal M: Oesophageal cancer: Risks, prevention, and diagnosis.
BMJ. 366:143732019.
|
|
5
|
Mariette C, Markar SR, Dabakuyo-Yonli TS,
Meunier B, Pezet D, Collet D, D'Journo XB, Brigand C, Perniceni T,
Carrère N, et al: Hybrid minimally invasive esophagectomy for
esophageal cancer. N Engl J Med. 380:152–162. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
He L and Hannon GJ: MicroRNAs: Small RNAs
with a big role in gene regulation. Nat Rev Genet. 5:522–531. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jiang M, Shi L, Yang C, Ge Y, Lin L, Fan
H, He Y, Zhang D, Miao Y and Yang L: MiR-1254 inhibits cell
proliferation, migration, and invasion by down-regulating Smurf1 in
gastric cancer. Cell Death Dis. 10:322019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang Z, Zhang Y, Sun XX, Ma X and Chen
ZN: MicroRNA-146a inhibits cancer metastasis by downregulating VEGF
through dual pathways in hepatocellular carcinoma. Mol Cancer.
14:11862015. View Article : Google Scholar
|
|
11
|
Garzon R, Calin GA and Croce CM: MicroRNAs
in cancer. Annu Rev Med. 60:167–179. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Troschel FM, Böhly N, Borrmann K, Braun T,
Schwickert A, Kiesel L, Eich HT, Götte M and Greve B: MiR-142-3p
attenuates breast cancer stem cell characteristics and decreases
radioresistance in vitro. Tumour Biol. 40:10104283187918872018.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wu Y, Huang J, Xu H and Gong Z:
Over-Expression of miR-15a-3p enhances the radiosensitivity of
cervical cancer by targeting tumor protein D52. Biomed
Pharmacother. 105:1325–1334. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shao Y, Zhang D, Li X, Yang J, Chen L,
Ning Z, Xu Y, Deng G, Tao M, Zhu Y and Jiang J: MicroRNA-203
increases cell radiosensitivity via directly targeting Bmi-1 in
hepatocellular carcinoma. Mol Pharm. 15:3205–3215. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang L, Peng X, Lu X, Wei Q, Chen M and
Liu L: Inhibition of hsa_circ_0001313 (circCCDC66) induction
enhances the radio-sensitivity of colon cancer cells via tumor
suppressor miR-338-3p: Effects of cicr_0001313 on colon cancer
radio-sensitivity. Pathol Res Pract. 215:689–696. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yu J, Wu SW and Wu WP: A tumor-suppressive
microRNA, miRNA-485-5p, inhibits glioma cell proliferation and
invasion by down-regulating TPD52L2. Am J Transl Res. 9:3336–3344.
2017.PubMed/NCBI
|
|
17
|
Wang R, Zuo X, Wang K, Han Q, Zuo J, Ni H,
Liu W, Bao H, Tu Y and Xie P: MicroRNA-485-5p attenuates cell
proliferation in glioma by directly targeting paired box 3. Am J
Cancer Res. 8:2507–2517. 2018.PubMed/NCBI
|
|
18
|
Chai Y, Du Y, Zhang S, Xiao J, Luo Z, He F
and Huang K: MicroRNA-485-5p reduces O-GlcNAcylation of Bmi-1 and
inhibits colorectal cancer proliferation. Exp Cell Res.
368:111–118. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hu XX, Xu XN, He BS, Sun HL, Xu T, Liu XX,
Chen XX, Zeng KX, Wang SK and Pan YQ: MicroRNA-485-5p functions as
a tumor suppressor in colorectal cancer cells by targeting CD147. J
Cancer. 9:2603–2611. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Han DL, Wang LL, Zhang GF, Yang WF, Chai
J, Lin HM, Fu Z and Yu JM: MiRNA-485-5p, inhibits esophageal cancer
cells proliferation and invasion by down-regulating O-linked
N-acetylglucosamine transferase. Eur Rev Med Pharmacol Sci.
23:2809–2816. 2019.PubMed/NCBI
|
|
21
|
Dam DHM, Jelsma SA, Yu JM, Liu H, Kong B
and Paller AS: Flotillin and AP2A1/2 promote IGF-1 receptor
association with clathrin and internalization in primary human
keratinocytes. J Invest Dermatol. 140:1743–1752. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sonnino S and Prinetti A: Membrane domains
and the ‘lipid raft’ concept. Curr Med Chem X20. 4–21. 2013.
|
|
23
|
George KS and Wu S: Lipid raft: A floating
island of death or survival. Toxicol Appl Pharmacol. 259:311–319.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ficht X, Ruef N, Stolp B, Samson GPB,
Moalli F, Page N, Merkler D, Nichols BJ, Diz-Muñoz A, Legler DF, et
al: In vivo function of the lipid raft protein flotillin-1 during
CD8(+) T cell-mediated host surveillance. J Immunol. 203:2377–2387.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lu SM and Fairn GD: Mesoscale organization
of domains in the plasma membrane-beyond the lipid raft. Crit Rev
Biochem Mol Biol. 53:192–207. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Affentranger S, Martinelli S, Hahn J,
Rossy J and Niggli V: Dynamic reorganization of flotillins in
chemokinestimulated human T-lymphocytes. BMC Cell Biol. 12:282011.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Guillaume E, Comunale F, Do Khoa N,
Planchon D, Bodin S and Gauthier-Rouviere C: Flotillin microdomains
stabilize cadherins at cell-cell junctions. J Cell Sci.
126:5293–5304. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Rice T, Ishwaran H, Hofstetter W, Kelsen
D, Apperson-Hansen C and Blackstone E; Worldwide Esophageal Cancer
Collaboration Investigators, : Recommendations for pathologic
staging (pTNM) of cancer of the esophagus and esophagogastric
junction for the 8th edition AJCC/UICC staging manuals. Dis
Esophagus. 29:897–905. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Dai SL, Wei SS, Zhang C, Li XY, Liu YP, Ma
M, Lv HL, Zhang Z, Zhao LM and Shan BE: MTA2 promotes the
metastasis of esophageal squamous cell carcinoma via EIF4E-twist
feedback loop. Cancer Sci. 19:147782020.
|
|
30
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Guo AY, Liang XJ, Liu RJ, Li XX, Bi W,
Zhou LY, Tang CE, Yan A, Chen ZC and Zhang PF: Flotilin-1 promotes
the tumorigenicity and progression of malignant phenotype in human
lung adenocarcinoma. Cancer Biol Ther. 18:715–722. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Huang RS, Zheng YL, Li C, Ding C, Xu C and
Zhao J: MicroRNA-485-5p suppresses growth and metastasis in
non-small cell lung cancer cells by targeting IGF2BP2. Life Sci.
199:104–111. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lee RC, Feinbaum RL and Ambros V: The C.
Elegans heterochronic gene lin-4 encodes small RNAs with antisense
complementarity to lin-14. Cell. 75:843–854. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Di Leva G, Garofalo M and Croce CM:
MicroRNAs in cancer. Annu Rev Pathol. 9:287–314. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chen H, Yao X, Di X, Zhang Y, Zhu H, Liu
S, Chen T, Yu D and Sun X: MiR-450a-5p inhibits autophagy and
enhances radiosensitivity by targeting dual-specificity phosphatase
10 in esophageal squamous cell carcinoma. Cancer Lett. 28:114–126.
2020. View Article : Google Scholar
|
|
36
|
Wang F, Li L, Piontek K, Sakaguchi M and
Selaru FM: Exosome miR-335 as a novel therapeutic strategy in
hepatocellular carcinoma. Hepatology. 67:940–954. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Qiu BQ, Lin XH, Ye XD, Huang W, Pei X,
Xiong D, Long X, Zhu SQ, Lu F, Lin K, et al: Long non-coding RNA
PSMA3-AS1 promotes malignant phenotypes of esophageal cancer by
modulating the miR-101/EZH2 axis as a ceRNA. Aging (Albany NY).
12:1843–1856. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang Y, Sun L, Wang L, Liu Z, Li Q, Yao B,
Wang C, Chen T, Tu K and Liu Q: Long non-coding RNA DSCR8 acts as a
molecular sponge for miR-485-5p to activate wnt/β-catenin signal
pathway in hepatocellular carcinoma. Cell Death Dis. 9:8512018.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Duan J, Zhang H, Li S, Wang X, Yang H,
Jiao S and Ba Y: The role of miR-485-5p/NUDT1 axis in gastric
cancer. Cancer Cell Int. 17:922017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Gao J, Dai C, Yu X, Yin XB and Zhou F:
MicroRNA-485-5p inhibits the progression of hepatocellular
carcinoma through blocking the WBP2/wnt signaling pathway. Cell
Signal. 66:1094662020. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhang Y, Hu J, Zhou W and Gao H: LncRNA
FOXD2-AS1 accelerates the papillary thyroid cancer progression
through regulating the miR-485-5p/KLK7 axis. J Cell Biochem.
19:10022018.
|
|
42
|
Li G and Kong Q: LncRNA LINC00460 promotes
the papillary thyroid cancer progression by regulating the
LINC00460/miR-485-5p/raf1 axis. Biol Res. 52:612019. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Bao W, Cao F, Ni S, Yang J, Li H, Su Z and
Zhao B: lncRNA FLVCR1-AS1 regulates cell proliferation, migration
and invasion by sponging miR-485-5p in human cholangiocarcinoma.
Oncol Lett. 18:2240–2247. 2019.PubMed/NCBI
|
|
44
|
Gao F, Wu H, Wang R, Guo Y, Zhang Z, Wang
T, Zhang G, Liu C and Liu J: MicroRNA-485-5p suppresses the
proliferation, migration and invasion of small cell lung cancer
cells by targeting flotillin-2. Bioengineered. 10:1–12. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Wang FR, Xu SH, Wang BM and Wang F:
MiR-485-5p inhibits metastasis and proliferation of osteosarcoma by
targeting CX3CL1. Eur Rev Med Pharmacol Sci. 22:7197–7204.
2018.PubMed/NCBI
|
|
46
|
Wang M, Cai WR, Meng R, Chi JR, Li YR,
Chen AX, Yu Y and Cao XC: MiR-485-5p suppresses breast cancer
progression and chemosensitivity by targeting survivin. Biochem
Biophys Res Commun. 501:48–54. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Lin C, Wu Z, Lin X, Yu C, Shi T, Zeng Y,
Wang X, Li J and Song L: Knockdown of FLOT1 impairs cell
proliferation and tumorigenicity in breast cancer through
upregulation of FOXO3a. Clin Cancer Res. 17:3089–3099. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Li Z, Yang Y, Gao Y, Wu X, Yang X, Zhu Y,
Yang H, Wu L, Yang C and Song L: Elevated expression of flotillin-1
is associated with lymph node metastasis and poor prognosis in
early-stage cervical cancer. Am J Cancer Res. 6:38–50. 2016.
|
|
49
|
Liu R, Xie H, Luo C, Chen Z, Zhou X, Xia
K, Chen X, Zhou M, Cao P, Cao K and Zhou J: Identification of FLOT2
as a novel target for microRNA-34a in melanoma. J Cancer Res Clin
Oncol. 141:993–1006. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Song L, Gong H, Lin C, Wang C, Liu L, Wu
J, Li M and Li J: Flotillin-1 promotes tumor necrosis factor-alpha
receptor signaling and activation of NF-κB in esophageal squamous
cell carcinoma cells. Gastroenterology. 143:995–1005. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Jang D, Kwon H, Choi M, Lee J and Pak Y:
Sumoylation of flotillin-1 promotes EMT in metastatic prostate
cancer by suppressing snail degradation. Oncogene. 38:3248–3260.
2019. View Article : Google Scholar : PubMed/NCBI
|
